Drug profile · INN
sepetaprost
SETANEO
sepetaprost (SETANEO) is a prostanoid ep3 receptor agonist.
PMDA: approved
Patents linked 0
Pipeline programs 0
News articles 0
Drug details — sepetaprost
- Class
- —
- Route
- —
- Patents
- 0
- Programs
- 0
- Data quality
- 0.78
Quick answer
sepetaprost (SETANEO) is a prostanoid ep3 receptor agonist.
Key facts
INN sepetaprost
Brand SETANEO
Mechanism Prostanoid EP3 receptor agonist
Target Prostaglandin E2 receptor EP3 subtype
Mechanism of action
Prostanoid EP3 receptor agonist
Primary target: Prostaglandin E2 receptor EP3 subtype
Approval history
| Authority | Status | Date |
|---|---|---|
| PMDA | approved | — |
Related & competitor drugs
Frequently asked questions
What is sepetaprost?
sepetaprost (SETANEO) is a prostanoid ep3 receptor agonist.
What is the brand name for sepetaprost?
SETANEO is a marketed brand name for sepetaprost. Check FDA Drugs@FDA for the current US label holder and prescribing information.